{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T23:47:26Z","timestamp":1768866446225,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13014-017-0915-8","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T07:44:33Z","timestamp":1510645473000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Conventional fractionation should not be the standard of care for T2 glottic cancer"],"prefix":"10.1186","volume":"12","author":[{"given":"Lynne M.","family":"Dixon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catriona M.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shazril Imran","family":"Shaukat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Garcez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lip Wai","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Slevin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"key":"915_CR1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"915_CR2","doi-asserted-by":"publisher","unstructured":"Dey P, Arnold D, Wight R, Kelly CG, MacKenzie K. Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. Cochrane Database Syst Rev. 2002;(2):CD002027. doi:\n10.1002\/14651858.CD002027\n\n.","DOI":"10.1002\/14651858.CD002027"},{"key":"915_CR3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/hed.20659","volume":"30","author":"I Vilaseca","year":"2008","unstructured":"Vilaseca I, Huerta P, Blanch JL, Fernandez-Planas AM, Jimenez C, Bernal-Sprekelsen M. Voice quality after CO2 laser cordectomy\u2014what can we really expect? Head Neck. 2008;30:43\u20139.","journal-title":"Head Neck"},{"key":"915_CR4","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1200\/JCO.2001.19.20.4029","volume":"19","author":"WM Mendenhall","year":"2001","unstructured":"Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW. T1\u2013T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol. 2001;19:4029\u201336.","journal-title":"J Clin Oncol"},{"key":"915_CR5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0360-3016(98)00062-5","volume":"41","author":"P Warde","year":"1998","unstructured":"Warde P, O\u2019Sullivan B, Bristow RG, Panzarella T, Keane T, Gullane P, et al. T1\/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control. Int J Radiat Oncol Biol Phys. 1998;41:347\u201353.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"915_CR6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/028418602317314091","volume":"41","author":"K Jorgensen","year":"2002","unstructured":"Jorgensen K, Godballe C, Hansen O, Bastholt L. Cancer of the larynx\u2014treatment results after primary radiotherapy with salvage surgery in a series of 1005 patients. Acta Oncol. 2002;41:69\u201376.","journal-title":"Acta Oncol"},{"key":"915_CR7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0360-3016(02)03938-X","volume":"55","author":"AS Garden","year":"2003","unstructured":"Garden AS, Forster K, Wong PF, Morrison WH, Schechter NR, Ang KK. Results of radiotherapy for T2N0 glottic carcinoma: does the \u201c2\u201d stand for twice-daily treatment? Int J Radiat Oncol Biol Phys. 2003;55:322\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"915_CR8","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ijrobp.2005.05.013","volume":"63","author":"P Frata","year":"2005","unstructured":"Frata P, Cellai E, Magrini SM, Bonetti B, Vitali E, Tonoli S, et al. Radical radiotherapy for early glottic cancer: results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. Int J Radiat Oncol Biol Phys. 2005;63:1387\u201394.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"915_CR9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijrobp.2009.08.066","volume":"78","author":"BS Chera","year":"2010","unstructured":"Chera BS, Amdur RJ, Morris CG, Kirwan JM, Mendenhall WM. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys. 2010;78(2):461\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"915_CR10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13014-015-0505-6","volume":"10","author":"E Ermi\u015f","year":"2015","unstructured":"Ermi\u015f E, Teo M, Dyker KE, Fosker C, Sen M, Prestwich RJD. Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions. Radiat Oncol. 2015;10:203.","journal-title":"Radiat Oncol"},{"key":"915_CR11","unstructured":"The Royal College of Radiologists. Radiotherapy dose-fractionation, 2nd edition. 2016. \nhttps:\/\/www.rcr.ac.uk\/publication\/radiotherapy-dose-fractionation-second-edition\n\n. Accessed 11 Jan 2017."},{"key":"915_CR12","first-page":"41","volume-title":"TNM classification of malignant tumors","year":"2009","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumors. 7th ed. Oxford: Wiley-Blackwell; 2009. p. 41.","edition":"7"},{"issue":"1","key":"915_CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0360-3016(93)90140-Q","volume":"25","author":"NJ Slevin","year":"1993","unstructured":"Slevin NJ, Vasanthan S, Dougal M. Relative clinical influence of tumor dose versus dose per fraction on the occurrence of late normal tissue morbidity following larynx radiotherapy. Int J Radiat Oncol Biol Phys. 1993;25(1):23\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"915_CR14","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events v4.0. NCI, NIH, DHHS. 2009. NIH publication # 09-7473."},{"issue":"4","key":"915_CR15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/hed.23641","volume":"37","author":"A Motegi","year":"2015","unstructured":"Motegi A, Kawashima M, Arahira S, Zenda S, Toshima M, Onozawa M, et al. Accelerated radiotherapy for T1 to T2 glottic cancer. Head Neck. 2015;37(4):579\u201384.","journal-title":"Head Neck"},{"issue":"S1","key":"915_CR16","doi-asserted-by":"crossref","first-page":"E179","DOI":"10.1002\/hed.23967","volume":"38","author":"D Berwouts","year":"2016","unstructured":"Berwouts D, Swimberghe M, Duprez F, Boterberg T, Bonte K, Deron P, et al. Intensity-modulated radiotherapy for early-stage glottic cancer. Head Neck. 2016;38(S1):E179\u201384.","journal-title":"Head Neck"},{"issue":"5","key":"915_CR17","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ijrobp.2014.04.041","volume":"89","author":"A Trotti","year":"2014","unstructured":"Trotti A, Zhang Q, Bentzen SM, Emami B, Hammond ME, Jones CU, et al. Randomized Trial of Hyperfractionation versus Conventional Fractionation in T2 Squamous Cell Carcinoma of the Vocal Cord (RTOG 9512). Int J Radiat Oncol Biol Phys. 2014;89(5):958\u201363.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"915_CR18","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/archotol.1990.01870070078014","volume":"116","author":"D Howell-Burke","year":"1990","unstructured":"Howell-Burke D, Peters LJ, Goepfert H, Oswald MJ. T2 glottic cancer. Recurrence, salvage, and survival after definitive radiotherapy. Arch Otolaryngol Head Neck Surg. 1990;116:830\u20135.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"915_CR19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.oraloncology.2016.10.013","volume":"62","author":"G Eskiizmir","year":"2016","unstructured":"Eskiizmir G, Bask\u0131n Y, Yal\u00e7\u0131n F, Ellidokuz H, Ferris RL. Risk factors for radiation failure in early-stage glottic carcinoma: a systematic review and meta-analysis. Oral Oncol. 2016;62:90\u2013100.","journal-title":"Oral Oncol"},{"issue":"S2","key":"915_CR20","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1017\/S0022215116000487","volume":"130","author":"TM Jones","year":"2016","unstructured":"Jones TM, De M, Foran B, Harrington K, Mortimore S. Laryngeal cancer: United Kingdom National Multidisciplinary guidelines. J Laryngol Otol. 2016;130(S2):S75\u201382.","journal-title":"J Laryngol Otol"},{"key":"915_CR21","series-title":"NICE guideline (NG36)","volume-title":"Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over","author":"National Institute for Health and Care Excellence","year":"2016","unstructured":"National Institute for Health and Care Excellence (2016) Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over. NICE guideline (NG36)."},{"issue":"4","key":"915_CR22","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/01.mlg.0000161329.75600.9d","volume":"115","author":"MM Barbosa","year":"2005","unstructured":"Barbosa MM, Ara\u00fajo VJ Jr, Boasquevisque E, Carvalho R, Romano S, Lima RA, et al. Anterior vocal commissure invasion in laryngeal carcinoma diagnosis. Laryngoscope. 2005;115(4):724\u201330.","journal-title":"Laryngoscope"},{"issue":"11","key":"915_CR23","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/hed.20071","volume":"26","author":"GA Champion","year":"2004","unstructured":"Champion GA, Piccirillo JF. The impact of computed tomography on pretherapeutic staging in patients with laryngeal cancer: demonstration of the will Rogers\u2019 phenomenon. Head Neck. 2004;26(11):972\u20136.","journal-title":"Head Neck."},{"issue":"1","key":"915_CR24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.radonc.2015.07.004","volume":"117","author":"NM Lyhne","year":"2015","unstructured":"Lyhne NM, Primdahl H, Kristensen CA, Andersen E, Johansen J, Andersen LJ, et al. The DAHANCA 6 randomized trial: effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma. Radiother Oncol. 2015;117(1):91\u20138.","journal-title":"Radiother Oncol"},{"key":"915_CR25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","volume":"62","author":"JF Fowler","year":"1989","unstructured":"Fowler JF. A review: the linear quadratic formula and progress in fractionated radiotherapy. Br J Radiology. 1989;62:679\u201394.","journal-title":"Br J Radiology"},{"issue":"4","key":"915_CR26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0167-8140(92)90226-K","volume":"24","author":"NJ Slevin","year":"1992","unstructured":"Slevin NJ, Hendry JH, Roberts SA, Agren-Cronqvist A. The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. Radiother Oncol. 1992;24(4):215\u201320. Erratum in: Radiother Oncol. 1992;25(3):227","journal-title":"Radiother Oncol"},{"key":"915_CR27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0167-8140(90)90096-F","volume":"17","author":"JM Taylor","year":"1990","unstructured":"Taylor JM, Withers HR, Mendenhall WM. Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation. Radiother Oncol. 1990;17:95\u2013102.","journal-title":"Radiother Oncol"},{"key":"915_CR28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0167-8140(99)00131-0","volume":"53","author":"JP Wylie","year":"1999","unstructured":"Wylie JP, Sen M, Swindell R, Sykes AJ, Farrington WT, Slevin NJ. Definitive radiotherapy for 114 cases of T3N0 glottic carcinoma: influence of dose-volume parameters on outcome. Radiother Oncol. 1999;53:15\u201321.","journal-title":"Radiother Oncol"},{"issue":"2","key":"915_CR29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0167-8140(03)00059-8","volume":"68","author":"RV Gowda","year":"2003","unstructured":"Gowda RV, Henk JM, Mais KL, Sykes AJ, Swindell R, Slevin NJ. Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience. Radiother Oncol. 2003;68(2):105\u201311.","journal-title":"Radiother Oncol"},{"issue":"6","key":"915_CR30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.clon.2009.02.008","volume":"21","author":"NL Cheah","year":"2009","unstructured":"Cheah NL, Lupton S, Marshall A, Hartley A, Glaholm J. Outcome of T1N0M0 squamous cell carcinoma of the larynx treated with short-course radiotherapy to a total dose of 50 Gy in 16 fractions: the Birmingham experience. Clin Oncol (R Coll Radiol). 2009;21(6):494\u2013501.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"915_CR31","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0360-3016(00)00635-0","volume":"48","author":"KA Dinshaw","year":"2000","unstructured":"Dinshaw KA, Sharma V, Agarwal JP, Ghosh S, Havaldar R. Radiation therapy in T1\u2013T2 glottic carcinoma: influence of various treatment parameters on local control\/complications. Int J Radiat Oncol Biol Phys. 2000;48(3):723\u201335.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"915_CR32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0360-3016(93)90005-G","volume":"25","author":"DA Fein","year":"1993","unstructured":"Fein DA, Mendenhall WM, Parsons JT, Million RR. T1\u2013T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control. Int J Radiat Oncol Biol Phys. 1993;25:605\u201311.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"915_CR33","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/hed.24520","volume":"38","author":"P Bhateja","year":"2016","unstructured":"Bhateja P, Ward MC, Hunter GH, Greskovich JF, Reddy CA, Nwizu TI, et al. Impaired vocal cord mobility in T2N0 glottic carcinoma: suboptimal local control with radiation alone. Head Neck. 2016;38:1832\u20136.","journal-title":"Head Neck"},{"issue":"4","key":"915_CR34","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ijrobp.2005.10.003","volume":"64","author":"T Akimoto","year":"2006","unstructured":"Akimoto T, Nonaka T, Kitamoto Y, Ishikawa H, Ninomiya H, Chikamatsu K, et al. Radiation therapy for T2N0 laryngeal cancer: a retrospective analysis for the impact of concurrent chemotherapy for local control. Int J Radiat Oncol Biol Phys. 2006;64(4):995\u20131001.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"915_CR35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1748-717X-7-122","volume":"7","author":"N Hirasawa","year":"2012","unstructured":"Hirasawa N, Itoh Y, Naganawa S, Ishihara S, Suzuki K, Koyama K, et al. Multi-institutional analysis of early glottic cancer from 2000 to 2005. Radiat Oncol. 2012;7:122.","journal-title":"Radiat Oncol"},{"key":"915_CR36","first-page":"Art No.: CD0020","volume":"12","author":"L Warner","year":"2014","unstructured":"Warner L, Chudasama J, Kelly CG, Loughran S, McKenzie K, Wight R, Dey P. Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. Cochrane Databse Syst Rev. 2014;12:Art No.: CD002027.","journal-title":"Cochrane Databse Syst Rev"},{"issue":"1","key":"915_CR37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hed.24534","volume":"39","author":"M Ansarin","year":"2017","unstructured":"Ansarin M, Cattaneo A, De Benedetto L, Zorzi S, Lombardi F, Alterio D, et al. Retrospective analysis of factors influencing oncologic outcome in 590 patients with early-intermediate glottic cancer treated by transoral laser microsurgery. Head Neck. 2017;39(1):71\u201381.","journal-title":"Head Neck"},{"key":"915_CR38","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.otohns.2007.05.064","volume":"137","author":"DG Grant","year":"2007","unstructured":"Grant DG, Salassa JR, Hinni ML, Pearson BW, Hayden RE, Perry WC. Transoral laser microsurgery for untreated glottic carcinoma. Otolaryngol Head Neck Surg. 2007;137:482\u20136.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"915_CR39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1749-4486.2010.02191.x","volume":"35","author":"PM Spielmann","year":"2010","unstructured":"Spielmann PM, Majumdar S, Morton RP. Quality of life and functional outcomes in the management of early glottis carcinoma: a systematic review of studies comparing radiotherapy and transoral laser microsurgery. Clin Otolaryngol. 2010;35:373\u201382.","journal-title":"Clin Otolaryngol"},{"key":"915_CR40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1749-4486.2009.01944.x","volume":"34","author":"PJ Bradley","year":"2009","unstructured":"Bradley PJ, Mackenzie K, Wright R, Pracy P, Paleri V. Consensus statement on management in the UK: transoral laser assisted microsurgical resection of early glottis cancer. Clin Otolaryngol. 2009;34:367\u201373.","journal-title":"Clin Otolaryngol"},{"key":"915_CR41","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/jrr\/rrs134","volume":"54","author":"K Karasawa","year":"2013","unstructured":"Karasawa K, Kunogi H, Hirai T, Hoji H, Hirowatari H, Izawa H, et al. Radiotherapy with fraction size of 2.25Gy in T1\u20132 laryngeal and hypopharyngeal cancer. J Radiat Res. 2013;54:684\u20139.","journal-title":"J Radiat Res"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-017-0915-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T07:44:53Z","timestamp":1510645493000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-017-0915-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["915"],"URL":"https:\/\/doi.org\/10.1186\/s13014-017-0915-8","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,14]]},"article-number":"178"}}